Apyx Medical Corporation to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021
Apyx Medical Corporation (NASDAQ:APYX) will release its financial results for Q1 2021 on May 12 before the market opens. A conference call is scheduled for 8:00 a.m. ET on the same day, where management will discuss the quarter's results and address questions. Interested listeners can join via phone or access the live webcast on the Company’s website. A telephonic replay of the call will be available shortly after, until May 21. Apyx Medical Corporation is known for its innovative Helium Plasma Technology, marketed as Renuvion® and J-Plasma®, in cosmetic and surgical markets.
- Scheduled release of Q1 2021 financial results could indicate transparency and commitment to investors.
- Innovative product lines, Renuvion® and J-Plasma®, highlight the company's focus on advanced medical technology.
- None.
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the first quarter of fiscal year 2021 will be released before the market opens on Wednesday, May 12.
Management will host a conference call at 8:00 a.m. Eastern Time on May 12 to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 877-407-8289 (or 201-689-8341 for international callers) and provide access code 13718670. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and at:
https://protect-us.mimecast.com/s/mSWhCNkEYzS9n1L4HRfmZ1?domain=78449.themediaframe.com.
A telephonic replay will be available approximately two hours after the end of the call through May 21, 2021. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13718670. The webcast will be archived on the Investor Relations section of the Company’s website.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company’s Helium Plasma Technology is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion® offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma® system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005883/en/
FAQ
When will Apyx Medical Corporation release its Q1 2021 financial results?
What time is the Apyx Medical Corporation conference call on May 12, 2021?
How can I listen to the Apyx Medical Corporation conference call?
What technologies does Apyx Medical Corporation focus on?
Is there a replay available for the Apyx Medical Corporation conference call?
